Buscar resultados de ensayos clínicos
Childhood Acute Lymphoblastic Leukemia - 25 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008 Condición: Childhood Acute Lymphoblastic Leukemia Fecha: 2013-09-26 Intervenciones:
|
Terminated |
Nombre del estudio: Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma Condición: B-Cell Pediatric ALL Fecha: 2014-08-21 Intervenciones: Drug: Moxetumomab Pasudotox Participants received 6 doses of moxetumomab pasudotox 40 microgram per kilo |
Recruiting |
Nombre del estudio: Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol Condición: Lymphoblastic Leukemia, Acute, Childhood Fecha: 2017-01-09 Intervenciones:
|
Recruiting |
Nombre del estudio: Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Condición: Childhood Acute Lymphoblastic Leukemia in Remission Fecha: 2012-01-03 Intervenciones:
|
Terminated |
Nombre del estudio: Treatment of Childhood Acute Lymphoblastic Leukemia Condición: Acute Lymphoblastic Leukemia Fecha: 2005-09-09 Intervenciones:
|
Completed |
Nombre del estudio: Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL Condición: Lymphoblastic Leukemia, Acute, Childhood Fecha: 2013-07-08 |
Completed |
Nombre del estudio: A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL) Condición: Lymphoblastic Leukemia, Acute, Childhood Fecha: 2009-10-05 Intervenciones: Drug: Clofarabine incorporated into a 5-drug regimen Clofarabine (IV) 40mg/m2 into an intensive chemothe |
Completed |
Nombre del estudio: Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) Condición: Recurrent Childhood Acute Lymphoblastic Leukemia Fecha: 2004-12-08 Intervenciones:
|
Completed |
Nombre del estudio: Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia Condición: Recurrent Childhood Acute Lymphoblastic Leukemia Fecha: 2004-08-04 Intervenciones:
|
Completed |
Nombre del estudio: Genomic Changes in Childhood Acute Lymphoblastic Leukemia Condición: Acute Lymphoblastic Leukemia Fecha: 2010-03-17 |